Tag: Emulgel

Emulgels are a novel class of topical formulations that combine the properties of both emulsions and gels. The primary driver for their development was overcoming the significant limitation of traditional gels, namely their inability to effectively deliver poorly water-soluble, or hydrophobic, drugs. This hybrid approach offers a powerful solution for enhanced therapeutic outcomes across dermatology, pain management, and more.

In 2020, the FDA approved Voltaren Arthritis Pain gel for over-the-counter use, making its prescription-strength formula widely available to consumers. This decision was largely due to its proven efficacy and a favorable safety profile, which helps explain why is Voltaren gel so good for providing localized and powerful arthritis pain relief.

According to the U.S. Food and Drug Administration (FDA), Voltaren gel became available over-the-counter (OTC) in February 2020 after a process known as an 'Rx-to-OTC switch'. This means that the American version of Voltaren, now branded as **Voltaren Arthritis Pain gel**, is widely available to consumers without a prescription. While known internationally as Voltaren Emulgel, the product found in U.S. stores contains the same key ingredient, diclofenac sodium.

According to research on musculoskeletal pain, topical analgesics are increasingly utilized for localized pain management. In this context, Rumol D roll on Emulgel provides targeted relief for various forms of joint and muscle pain, delivering its potent anti-inflammatory and analgesic properties directly to the affected area.